Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
728
NCT00535028
A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2005
Completion: May 31, 2005
NCT00535431
Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics
Start: Dec 31, 2005
Completion: Oct 31, 2006
NCT00676884
A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema
Start: Feb 28, 2006
Completion: Aug 31, 2006
NCT00785668
A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects
Phase: Phase 1
Start: Nov 30, 2007
Completion: Feb 29, 2008
NCT00801853
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
Start: Mar 31, 2009
Completion: Feb 28, 2010
NCT02310490
DA-13-007 Versus Sculptra for the Treatment of Nasolabial Folds Wrinkles
Phase: N/A
Start: Jan 31, 2015
Completion: Dec 31, 2018
NCT04955106
Evaluation of the Sub Epidermal Moisture a Device for the Screening of Pressure Ulcer (RELIASEM)
Start: Jun 22, 2021
Completion: Dec 31, 2021